# The relationship between mixed exposure to blood metal and serum neurofilament light chain levels in the general U.S. population: an unsupervised clustering approach

**Authors:** Jiyu Nie, Lin Wen, Zhentian Lai, Chuhang Lin, Haiyin Li, Jing Zhang, Shen Xie, Xiaosong Ben, Chunxia Jing

PMC · DOI: 10.3389/fpubh.2025.1516879 · 2025-07-30

## TL;DR

This study finds that higher blood cadmium levels are linked to increased signs of neuronal injury in the general U.S. population.

## Contribution

A novel unsupervised clustering approach is used to explore mixed metal exposure and its association with a neuronal injury biomarker.

## Key findings

- Blood cadmium levels are significantly associated with elevated serum neurofilament light chain (sNfL) levels.
- Cadmium is identified as the dominant contributor to sNfL elevation in high-exposure subgroups.
- The effect of cadmium on sNfL is stronger in males and individuals with higher BMI.

## Abstract

Serum neurofilament light chain (sNfL) has demonstrate significant clinical value in quantifying neuronal injury. Concurrently, extensive evidence has linked metal exposure to neurotoxic effects. However, the potential association between metal exposure and circulating sNfL levels remains uninvestigated in population-based study.

We applied a novel unsupervised clustering method (k-medoids) incorporating blood metals concentrations to stratify the general U. S. population into different exposure profiles to investigate the association between metal exposure and sNfL levels.

We analyzed data from the 2013–2014 NHANES cycle, and 513 participants were included in this study. Multivariate regression model, Bayesian kernel regression (BKMR) and quantile g-computation (QGC) were used to assess the relationship between individual and mixed metal exposure and sNfL.

Multivariate regression revealed a significant positive association between blood cadmium concentrations and elevated sNfL levels in the overall population (β = 0.115, 95%CI: 0.039–0.190, p = 0.003). Through exposure pattern recognition using unsupervised k-medoids clustering, participants were stratified into distinct exposure subgroups: a high-exposure cluster (n = 326) and a low-exposure (n = 187) reference group. BKMR modeling within the high-exposure group identified cadmium as the dominant contributor to sNfL elevation, with stronger effects in male participants (β = 0.201, 95%CI: 0.087–0.315) and individuals with BMI > 25 kg/m2 (β = 0.178, 95%CI: 0.062–0.294).

This study provides systematic evidence that blood cadmium concentration can be used as the predominant driver of early neuronal injury, as objectively quantified through sNfL biomarker.

## Linked entities

- **Chemicals:** cadmium (PubChem CID 23973)

## Full-text entities

- **Genes:** Nlrp3 (NLR family, pyrin domain containing 3) [NCBI Gene 287362] {aka Cias1}, NEFL (neurofilament light chain) [NCBI Gene 4747] {aka CMT1F, CMT2E, CMTDIG, NF-L, NF68, NFL}, GSR (glutathione-disulfide reductase) [NCBI Gene 2936] {aka CNSHA10, GR, GSRD, HEL-75, HEL-S-122m}, Tnf (tumor necrosis factor) [NCBI Gene 24835] {aka RATTNF, TNF-alpha, Tnfa}, Il6 (interleukin 6) [NCBI Gene 24498] {aka ILg6, Ifnb2}, Bdnf (brain-derived neurotrophic factor) [NCBI Gene 24225], NFASC (neurofascin) [NCBI Gene 23114] {aka NEDCPMD, NF, NRCAML}, Mapk8 (mitogen-activated protein kinase 8) [NCBI Gene 116554] {aka JNK}, Il10 (interleukin 10) [NCBI Gene 25325] {aka IL10X, If2a}, Creb1 (cAMP responsive element binding protein 1) [NCBI Gene 81646] {aka Creb}, ZNF746 (zinc finger protein 746) [NCBI Gene 155061] {aka PARIS}
- **Diseases:** lead poisoning (MESH:D007855), cardiovascular and cerebrovascular diseases (MESH:D002318), axonal damage (MESH:D001480), neurotoxic (MESH:D020258), HL (MESH:C538324), NAFLD (MESH:D065626), Alzheimer's disease (MESH:D000544), hippocampus-dependent learning (MESH:D007859), heart disease (MESH:D006331), Hyperuricemia (MESH:D033461), coronary heart disease (MESH:D003327), multiple sclerosis (MESH:D009103), inflammatory (MESH:D007249), neurological damage (MESH:D020196), neuronal (MESH:D009410), adiposity (MESH:D018205), neurological impairment (MESH:D009422), neurodegeneration (MESH:D019636), depression (MESH:D003866), stroke (MESH:D020521), spinal contusion (MESH:D013119), cognitive decline (MESH:D003072), mitochondrial dysfunction (MESH:D028361), QGC (MESH:C000719218), neural injury (MESH:D014947), frontotemporal dementia (MESH:D057180), obesity (MESH:D009765), nerve damage (MESH:D000080902), atrophy (MESH:D001284), overweight (MESH:D050177), toxicity (MESH:D064420), detrimental effects on neurological function (MESH:D003291), angina (MESH:D000787), neuroinflammation (MESH:D000090862), neurological diseases (MESH:D020271), sNfL (MESH:D000075363), progressive supranuclear palsy (MESH:D013494), Hypertension (MESH:D006973), amyotrophic lateral sclerosis (MESH:D000690), congestive heart failure (MESH:D006333)
- **Chemicals:** alcohol (MESH:D000438), glutathione (MESH:D005978), Cadmium (MESH:D002104), calcium (MESH:D002118), PMP (MESH:C091421), Pb (MESH:D007854), metal (MESH:D008670), ROS (MESH:D017382), Cu (MESH:D003300), Manganese (MESH:D008345), iron (MESH:D007501), acridine (MESH:D000166), QGC (-), magnesium (MESH:D008274), Se (MESH:D012643), creatinine (MESH:D003404), Hg (MESH:D008628), Zinc (MESH:D015032), thiol (MESH:D013438), Heavy metals (MESH:D019216)
- **Species:** Homo sapiens (human, species) [taxon 9606], Rattus norvegicus (brown rat, species) [taxon 10116], Mus musculus (house mouse, species) [taxon 10090]
- **Cell lines:** SH-SY5Y — Homo sapiens (Human), Neuroblastoma, Cancer cell line (CVCL_0019), PC12 — Rattus norvegicus (Rat), Rat adrenal gland pheochromocytoma, Cancer cell line (CVCL_0481)

## Figures

8 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12343511/full.md

---
Source: https://tomesphere.com/paper/PMC12343511